Fulcrum Therapeutics, Inc. (FULC) vs InflaRx N.V. (IFRX)
Fulcrum Therapeutics, Inc. and InflaRx N.V. are both Biotechnology companies. Fulcrum Therapeutics, Inc. and InflaRx N.V. are of similar size ($288.8M and $284.4M). Fulcrum Therapeutics, Inc. grew revenue faster over the last twelve months: 1,939.8% against −83.4%. Across the 12 metrics below, Fulcrum Therapeutics, Inc. leads on 8 and InflaRx N.V. on 4.
Valuation
Profitability
| Metric | FULC | IFRX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | (26,762.42%) | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (32.38%) | (38.71%) | (57.72%) |
| Return on assets | (30.75%) | (32.75%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack